{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:43:32Z","timestamp":1792604612208,"version":"4.5.0"},"reference-count":147,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.heliyon.2023.e18991","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T20:55:44Z","timestamp":1691441744000},"page":"e18991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Chronic kidney disease and gut microbiota"],"prefix":"10.1016","volume":"9","author":[{"given":"Siamak","family":"Amini Khiabani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Asgharzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6026-8795","authenticated-orcid":false,"given":"Hossein","family":"Samadi Kafil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.heliyon.2023.e18991_bib1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2215\/CJN.09990819","article-title":"Systems biology and kidney disease","volume":"15","author":"Schaub","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"13","key":"10.1016\/j.heliyon.2023.e18991_bib2","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management: a review","volume":"322","author":"Chen","year":"2019","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e18991_bib3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1590\/2175-8239-jbn-3931","article-title":"Probiotics in the treatment of chronic kidney disease: a systematic review","volume":"40","author":"Fagundes","year":"2018","journal-title":"J Bras Nefrol"},{"key":"10.1016\/j.heliyon.2023.e18991_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6622179","article-title":"Renal replacement modality affects uremic toxins and oxidative stress","volume":"2021","author":"Niemczyk","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e18991_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13040246","article-title":"Uremic toxins and blood purification: a review of current evidence and future perspectives","volume":"13","author":"Magnani","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.heliyon.2023.e18991_bib6","series-title":"Your Kidney & How They Work","year":"2002"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e18991_bib7","first-page":"705","article-title":"End-stage renal disease: symptom management and advance care planning","volume":"85","author":"O'Connor","year":"2012","journal-title":"Am. Fam. Physician"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e18991_bib8","first-page":"1401","article-title":"[Gut microbiota in renal transplant recipients, patients with chronic kidney disease and healthy subjects]","volume":"38","author":"Guirong","year":"2018","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib9","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1038\/s41598-020-59794-7","article-title":"Infection in advanced chronic kidney disease and subsequent adverse outcomes after dialysis initiation: a nationwide cohort study","volume":"10","author":"Chang","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e18991_bib10","article-title":"Causes and complications of chronic kidney disease in patients on dialysis Health","volume":"8","author":"Eleftheria Tzanakaki","year":"2014","journal-title":"Sci. J."},{"key":"10.1016\/j.heliyon.2023.e18991_bib11","series-title":"Guide For Patients","year":"2013"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e18991_bib12","first-page":"452","article-title":"Long-term survival of patients with end-stage renal disease on maintenance hemodialysis: a multicenter study in Iran","volume":"6","author":"Beladi-Mousavi","year":"2012","journal-title":"Iran J Kidney Dis"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1681\/ASN.2018050531","article-title":"Projecting ESRD incidence and prevalence in the United States through 2030","volume":"30","author":"McCullough","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s12882-020-02047-6","article-title":"Epidemiology of dialysis-treated end-stage renal disease patients in Kazakhstan: data from nationwide large-scale registry 2014-2018","volume":"21","author":"Gaipov","year":"2020","journal-title":"BMC Nephrol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e18991_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.34172\/ijer.2020.11","article-title":"Epidemiological characteristics and causes of end-stage renal disease in hemodialysis patients","volume":"7","author":"Khazaei","year":"2020","journal-title":"International Journal of Epidemiologic Research"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12882-019-1224-2","article-title":"Clinical outcomes of hemodialysis patients in a public-private partnership care framework in Italy: a retrospective cohort study","volume":"20","author":"Pedrini","year":"2019","journal-title":"BMC Nephrol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e18991_bib17","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from Kidney Disease: improving Global Outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1242\/dmm.017400","article-title":"How informative is the mouse for human gut microbiota research?","volume":"8","author":"Nguyen","year":"2015","journal-title":"Dis Model Mech"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e18991_bib19","doi-asserted-by":"crossref","first-page":"G922","DOI":"10.1152\/ajpgi.2001.280.5.G922","article-title":"The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo","volume":"280","author":"Atuma","year":"2001","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/imm.12231","article-title":"The microbiome and regulation of mucosal immunity","volume":"142","author":"McDermott","year":"2014","journal-title":"Immunology"},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2023.e18991_bib21","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1513\/AnnalsATS.201306-161MG","article-title":"Mucosal immunity and the microbiome","volume":"11","author":"Neish","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.heliyon.2023.e18991_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-1-4939-0897-4_3","article-title":"The enteric nervous system and gastrointestinal innervation: integrated local and central control","volume":"817","author":"Furness","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.heliyon.2023.e18991_bib23","doi-asserted-by":"crossref","first-page":"C350","DOI":"10.1152\/ajpcell.00191.2015","article-title":"Physiologic hypoxia and oxygen homeostasis in the healthy intestine. A review in the theme: cellular responses to hypoxia","volume":"309 6","author":"Zheng","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e18991_bib24","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41581-018-0018-2","article-title":"The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease","volume":"14","author":"Yang","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e18991_bib25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000381990","article-title":"The gut as a source of inflammation in chronic kidney disease","volume":"130","author":"Lau","year":"2015","journal-title":"Nephron"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e18991_bib26","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1053\/j.jrn.2017.02.010","article-title":"The leaky gut and altered microbiome in chronic kidney disease","volume":"27","author":"Lau","year":"2017","journal-title":"J. Ren. Nutr."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e18991_bib27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/j.ajkd.2015.09.027","article-title":"Role of the gut microbiome in uremia: a potential therapeutic target","volume":"67","author":"Ramezani","year":"2016","journal-title":"Am. J. Kidney Dis."},{"issue":"13","key":"10.1016\/j.heliyon.2023.e18991_bib28","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.3390\/ijms21134777","article-title":"NRF2, a transcription factor for stress response and beyond","volume":"21","author":"He","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010483","article-title":"Gut microbiota as a source of uremic toxins","volume":"23","author":"Popkov","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2023.e18991_bib30","article-title":"The composition of the gut microbiota throughout life, with an emphasis on early life","volume":"26","author":"Rodr\u00edguez","year":"2015","journal-title":"Microb. Ecol. Health Dis."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e18991_bib31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.molmed.2014.12.002","article-title":"The infant microbiome development: mom matters","volume":"21","author":"Mueller","year":"2015","journal-title":"Trends Mol. Med."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e18991_bib32","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1016\/j.celrep.2018.02.060","article-title":"Diet, genetics, and the gut microbiome drive dynamic changes in plasma metabolites","volume":"22","author":"Fujisaka","year":"2018","journal-title":"Cell Rep."},{"issue":"6052","key":"10.1016\/j.heliyon.2023.e18991_bib33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.1208344","article-title":"Linking long-term dietary patterns with gut microbial enterotypes","volume":"334","author":"Wu","year":"2011","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3945\/ajcn.112.056689","article-title":"Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans","volume":"98","author":"Ou","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32221-8","article-title":"The human gut pan-microbiome presents a compositional core formed by discrete phylogenetic units","volume":"8","author":"Aguirre de C\u00e1rcer","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib36","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41598-019-57106-2","article-title":"Intestinal barrier function is maintained with aging \u2013 a comprehensive study in healthy subjects and irritable bowel syndrome patients","volume":"10","author":"Wilms","year":"2020","journal-title":"Sci. Rep."},{"issue":"30","key":"10.1016\/j.heliyon.2023.e18991_bib37","doi-asserted-by":"crossref","first-page":"12450","DOI":"10.1073\/pnas.1300833110","article-title":"Rapid evolution of the human gut virome","volume":"110","author":"Minot","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"30","key":"10.1016\/j.heliyon.2023.e18991_bib38","doi-asserted-by":"crossref","first-page":"E6166","DOI":"10.1073\/pnas.1706359114","article-title":"Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children","volume":"114","author":"Zhao","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e18991_bib39","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nri.2017.55","article-title":"Fungal dysbiosis: immunity and interactions at mucosal barriers","volume":"17","author":"Iliev","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.heliyon.2023.e18991_bib40","article-title":"Gut mycobiome in patients with chronic kidney disease was altered and associated with immunological profiles","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e18991_bib41","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1128\/CMR.00008-07","article-title":"Bacteroides: the good, the bad, and the nitty-gritty","volume":"20","author":"Wexler","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e18991_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009056","article-title":"Strain diversity in the microbiome: lessons from Bacteroides fragilis","volume":"16","author":"Carrow","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.heliyon.2023.e18991_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104506","article-title":"To resist and persist: important factors in the pathogenesis of Bacteroides fragilis","volume":"149","author":"Yekani","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.heliyon.2023.e18991_bib44","first-page":"1","article-title":"Bifidobacterium spp. as functional foods: a review of current status, challenges, and strategies","author":"He","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.heliyon.2023.e18991_bib45","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3389\/fmicb.2016.01204","article-title":"Gut Bifidobacteria populations in human health and aging","volume":"7","author":"Arboleya","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.heliyon.2023.e18991_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105667","article-title":"Clostridium species diversity in gut microbiota of patients with renal failure","volume":"169","author":"Khiabani","year":"2022","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib47","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1038\/s41598-017-02989-2","article-title":"Alteration of the gut microbiota in Chinese population with chronic kidney disease","volume":"7","author":"Jiang","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib48","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40104-019-0402-1","article-title":"Clostridium species as probiotics: potentials and challenges","volume":"11","author":"Guo","year":"2020","journal-title":"J. Anim. Sci. Biotechnol."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e18991_bib49","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41575-022-00610-0","article-title":"Capturing the environment of the Clostridioides difficile infection cycle","volume":"19","author":"Schnizlein","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e18991_bib50","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10096-019-03539-6","article-title":"Clostridium difficile infection: review","volume":"38","author":"Czepiel","year":"2019","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e18991_bib51","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3390\/toxins12100650","article-title":"Molecular characterization of Clostridium perfringens strains isolated in Italy","volume":"12","author":"Forti","year":"2020","journal-title":"Toxins"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e18991_bib52","first-page":"308","article-title":"The human gut microbiota: metabolism and perspective in obesity","volume":"9","author":"Gomes","year":"2018","journal-title":"Gut Microb."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e18991_bib53","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.jksus.2020.03.015","article-title":"Lactobacilli species diversity in gut microbiota of renal failure patients","volume":"32","author":"Hanifi","year":"2020","journal-title":"J. King Saud Univ. Sci."},{"key":"10.1016\/j.heliyon.2023.e18991_bib147","series-title":"Brock biology of microorganisms","author":"Clark","year":"2011"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e18991_bib54","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ni1079","article-title":"Getting a grip on things: how do communities of bacterial symbionts become established in our intestine?","volume":"5","author":"Sonnenburg","year":"2004","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e18991_bib55","doi-asserted-by":"crossref","first-page":"420","DOI":"10.7150\/ijbs.37421","article-title":"Gut microbiota as diagnostic tools for mirroring disease progression and circulating nephrotoxin levels in chronic kidney disease: discovery and validation study","volume":"16","author":"Wu","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib56","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12967-018-1756-4","article-title":"Microbiome\u2013metabolome reveals the contribution of gut\u2013kidney axis on kidney disease","volume":"17","author":"Chen","year":"2019","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e18991_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105354","article-title":"Short-chain fatty acids in chronic kidney disease: focus on inflammation and oxidative stress regulation","volume":"23","author":"Magliocca","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib58","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12882-020-01805-w","article-title":"The gut microbiota profile of adults with kidney disease and kidney stones: a systematic review of the literature","volume":"21","author":"Stanford","year":"2020","journal-title":"BMC Nephrol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e18991_bib59","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ki.2012.345","article-title":"Chronic kidney disease alters intestinal microbial flora","volume":"83","author":"Vaziri","year":"2013","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e18991_bib60","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211053276","article-title":"Association between gut dysbiosis and chronic kidney disease: a narrative review of the literature","volume":"49","author":"Feng","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.heliyon.2023.e18991_bib61","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/bs.aambs.2016.06.002","article-title":"The role of the gut microbiome on chronic kidney disease","volume":"96","author":"Sampaio-Maia","year":"2016","journal-title":"Adv. Appl. Microbiol."},{"key":"10.1016\/j.heliyon.2023.e18991_bib62","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fcimb.2019.00206","article-title":"Alterations to the gut microbiota and their correlation with inflammatory factors in chronic kidney disease","volume":"9","author":"Li","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.heliyon.2023.e18991_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.726256","article-title":"Uremic toxin-producing Bacteroides species prevail in the gut microbiota of Taiwanese CKD patients: an analysis using the new taiwan microbiome baseline","volume":"12","author":"Shivani","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e18991_bib64","first-page":"521","article-title":"Bifidobacteriaceae family diversity in gut microbiota of patients with renal failure","volume":"76","author":"Hanifi","year":"2021","journal-title":"Arch Razi Inst"},{"issue":"3\u20134","key":"10.1016\/j.heliyon.2023.e18991_bib65","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000369817","article-title":"Uremic toxins and their effects on multiple organ systems","volume":"128","author":"Lisowska-Myjak","year":"2014","journal-title":"Nephron Clin. Pract."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e18991_bib66","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/toxins14030177","article-title":"The interplay between uremic toxins and albumin, membrane transporters and drug interaction","volume":"14","author":"Cunha","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.heliyon.2023.e18991_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.592602","article-title":"Uremic toxins in organ crosstalk","volume":"8","author":"Lowenstein","year":"2021","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e18991_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9020052","article-title":"p-Cresyl Sulfate","volume":"9","author":"Gryp","year":"2017","journal-title":"Toxins"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e18991_bib69","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1093\/ndt\/gfx089","article-title":"p-Cresyl glucuronide is a major metabolite of p-cresol in mouse: in contrast to p-cresyl sulphate, p-cresyl glucuronide fails to promote insulin resistance","volume":"32","author":"Koppe","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e18991_bib70","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5935\/0101-2800.20160024","article-title":"p-cresol but not p-cresyl sulfate stimulate MCP-1 production via NF-\u03baB p65 in human vascular smooth muscle cells","volume":"38","author":"Maciel","year":"2016","journal-title":"J Bras Nefrol"},{"issue":"34","key":"10.1016\/j.heliyon.2023.e18991_bib71","doi-asserted-by":"crossref","first-page":"14728","DOI":"10.1073\/pnas.0904489106","article-title":"Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism","volume":"106","author":"Clayton","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e18991_bib72","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/hdi.12483","article-title":"Indoxyl sulfate, a valuable biomarker in chronic kidney disease and dialysis","volume":"21","author":"Tan","year":"2017","journal-title":"Hemodial. Int."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib73","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12882-017-0457-1","article-title":"Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease","volume":"18","author":"Kami\u0144ski","year":"2017","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.heliyon.2023.e18991_bib74","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/512178","article-title":"Classification of five uremic solutes according to their effects on renal tubular cells","author":"Edamatsu","year":"2014","journal-title":"Internet J. Nephrol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e18991_bib75","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.celrep.2018.06.096","article-title":"A multi-omic association study of trimethylamine N-oxide","volume":"24","author":"Manor","year":"2018","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib76","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/s41598-020-80122-6","article-title":"Gut microbiota derived trimethylamine N-oxide (TMAO) detection through molecularly imprinted polymer based sensor","volume":"11","author":"Lakshmi","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2023.e18991_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.675158","article-title":"Gut-derived metabolite phenylacetylglutamine and white matter hyperintensities in patients with acute ischemic stroke","volume":"13","author":"Yu","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"10\u201311","key":"10.1016\/j.heliyon.2023.e18991_bib78","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1159\/000519811","article-title":"The kynurenine pathway in acute kidney injury and chronic kidney disease","volume":"52","author":"Wee","year":"2021","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.heliyon.2023.e18991_bib79","doi-asserted-by":"crossref","DOI":"10.1177\/1178646920954882","article-title":"Kynurenine pathway in chronic kidney disease: what's old, what's new, and what's next?","volume":"13","author":"Mor","year":"2020","journal-title":"Int. J. Tryptophan Res."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e18991_bib80","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1556\/2060.106.2019.19","article-title":"The gut-kidney-heart axis in chronic kidney disease","volume":"106","author":"Sumida","year":"2019","journal-title":"Phys. Int."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e18991_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10070298","article-title":"Intestinal barrier function in chronic kidney disease","volume":"10","author":"Meijers","year":"2018","journal-title":"Toxins"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e18991_bib82","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1681\/ASN.2013080905","article-title":"The gut microbiome, kidney disease, and targeted interventions","volume":"25","author":"Ramezani","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.heliyon.2023.e18991_bib83","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2147\/JIR.S306789","article-title":"Changes of lipopolysaccharide-induced acute kidney and liver injuries in rats based on metabolomics analysis","volume":"14","author":"Gao","year":"2021","journal-title":"J. Inflamm. Res."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e18991_bib84","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1136\/gutjnl-2017-315734","article-title":"Understanding the gut-kidney axis in nephrolithiasis: an analysis of the gut microbiota composition and functionality of stone formers","volume":"67","author":"Ticinesi","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.heliyon.2023.e18991_bib85","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.micpath.2017.06.009","article-title":"Role of gut microbiota against calcium oxalate","volume":"109","author":"Sadaf","year":"2017","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib86","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1038\/s41598-022-07796-y","article-title":"Gut microbiota and the prevalence and incidence of renal stones","volume":"12","author":"Kim","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2023.e18991_bib87","doi-asserted-by":"crossref","first-page":"25","DOI":"10.14777\/uti.2021.16.2.25","article-title":"Impact of the human microbiome on nephrolithiasis","volume":"16","author":"Jung","year":"2021","journal-title":"Urogenital Tract Infection"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib88","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00467-017-3652-1","article-title":"The gut-kidney axis in IgA nephropathy: role of microbiota and diet on genetic predisposition","volume":"33","author":"Coppo","year":"2018","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.heliyon.2023.e18991_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.557368","article-title":"A comparative study of the gut microbiota associated with immunoglobulin a nephropathy and membranous nephropathy","volume":"10","author":"Dong","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"23","key":"10.1016\/j.heliyon.2023.e18991_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239254","article-title":"Secretory IgA in intestinal mucosal secretions as an adaptive barrier against microbial cells","volume":"21","author":"Pietrzak","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib91","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12882-021-02315-z","article-title":"Gut microbiota in immunoglobulin A nephropathy: a Malaysian perspective","volume":"22","author":"Sugurmar","year":"2021","journal-title":"BMC Nephrol."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e18991_bib92","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1159\/000509997","article-title":"A personalized update on IgA nephropathy: a new vision and new future challenges","volume":"144","author":"Guti\u00e9rrez","year":"2020","journal-title":"Nephron"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib93","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/MOG.0000000000000139","article-title":"The gut microbiome in health and in disease","volume":"31","author":"Shreiner","year":"2015","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.heliyon.2023.e18991_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2018.03.003","article-title":"Gut microbiota dysbiosis is associated with Henoch-Sch\u00f6nlein Purpura in children","volume":"58","author":"Wang","year":"2018","journal-title":"Int. Immunopharm."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e18991_bib95","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/ndt\/gfm781","article-title":"External suppression causes the low expression of the Cosmc gene in IgA nephropathy","volume":"23","author":"Qin","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib96","first-page":"4","article-title":"Stereotypes about enterotype: the old and new ideas","volume":"17","author":"Cheng","year":"2019","journal-title":"Dev. Reprod. Biol."},{"issue":"7346","key":"10.1016\/j.heliyon.2023.e18991_bib97","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nature09944","article-title":"Enterotypes of the human gut microbiome","volume":"473","author":"Arumugam","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2023.e18991_bib98","series-title":"Absence of Enterotypes in the Human Gut Microbiomes Reanalyzed with Non-linear Dimensionality Reduction Methods","author":"Bulygin","year":"2021"},{"key":"10.1016\/j.heliyon.2023.e18991_bib99","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40168-016-0160-7","article-title":"Interpreting Prevotella and Bacteroides as biomarkers of diet and lifestyle","volume":"4","author":"Gorvitovskaia","year":"2016","journal-title":"Microbiome"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib100","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2020.1847627","article-title":"Microbial enterotypes beyond genus level: Bacteroides species as a predictive biomarker for weight change upon controlled intervention with arabinoxylan oligosaccharides in overweight subjects","volume":"12","author":"Christensen","year":"2020","journal-title":"Gut Microb."},{"key":"10.1016\/j.heliyon.2023.e18991_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.740990","article-title":"Characterizing enterotypes in human metagenomics: a viral perspective","volume":"12","author":"Song","year":"2021","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib102","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/ki.2011.314","article-title":"Systems biology of kidney diseases","volume":"81","author":"He","year":"2012","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e18991_bib103","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/ndt\/gfv364","article-title":"The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease","volume":"31","author":"Cisek","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02282-3","article-title":"Systems biology and machine learning approaches identify drug targets in diabetic nephropathy","volume":"11","author":"Abedi","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2023.e18991_bib105","series-title":"Membranous Nephropathy: Systems Biology-Based Novel Mechanism and Traditional Chinese Medicine Therapy","author":"Miao","year":"2022"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e18991_bib106","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4161\/gmic.1.5.12925","article-title":"The interaction of gut microbes with host ABC transporters","volume":"1","author":"Mercado-Lubo","year":"2010","journal-title":"Gut Microb."},{"issue":"38","key":"10.1016\/j.heliyon.2023.e18991_bib107","doi-asserted-by":"crossref","first-page":"15789","DOI":"10.1074\/jbc.M117.796516","article-title":"The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis","volume":"292","author":"Bush","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib108","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47798-x","article-title":"A network of SLC and ABC transporter and DME genes involved in Remote sensing and signaling in the gut-liver-kidney Axis","volume":"9","author":"Rosenthal","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib109","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1038\/s41598-017-04949-2","article-title":"Key role for the organic anion transporters, OAT1 and OAT3, in the in vivo handling of uremic toxins and solutes","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2023.e18991_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.coemr.2021.07.001","article-title":"Recent advances and future directions in microbiome metabolomics","volume":"20","author":"Misheva","year":"2021","journal-title":"Current Opinion in Endocrine and Metabolic Research"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e18991_bib111","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00055-20","article-title":"Mucosal microbiota and metabolome along the intestinal tract reveal a location-specific relationship","volume":"5","author":"Yuan","year":"2020","journal-title":"mSystems"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e18991_bib112","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00055-20","article-title":"Mucosal microbiota and metabolome along the intestinal tract reveal a location-specific relationship","volume":"5","author":"Yuan","year":"2020","journal-title":"mSystems"},{"key":"10.1016\/j.heliyon.2023.e18991_bib113","article-title":"The role of gut microbiota and microbiota-related serum metabolites in the progression of diabetic kidney disease","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e18991_bib114","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41401-018-0029-3","article-title":"Magnesium lithospermate B improves the gut microbiome and bile acid metabolic profiles in a mouse model of diabetic nephropathy","volume":"40","author":"Zhao","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.heliyon.2023.e18991_bib115","article-title":"Characteristics of serum metabolites and gut microbiota in diabetic kidney disease","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e18991_bib116","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3390\/metabo10050181","article-title":"Metabolome\u2013microbiome crosstalk and human disease","volume":"10","author":"Lee-Sarwar","year":"2020","journal-title":"Metabolites"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e18991_bib117","doi-asserted-by":"crossref","DOI":"10.3390\/metabo10050181","article-title":"Metabolome-microbiome crosstalk and human disease","volume":"10","author":"Lee-Sarwar","year":"2020","journal-title":"Metabolites"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e18991_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12090775","article-title":"Interaction between plasma metabolomics and intestinal microbiome in db\/db mouse, an animal model for study of type 2 diabetes and diabetic kidney disease","volume":"12","author":"Wu","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.heliyon.2023.e18991_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.780924","article-title":"Rhubarb enema decreases circulating trimethylamine N-oxide level and improves renal fibrosis accompanied with gut microbiota change in chronic kidney disease rats","volume":"12","author":"Ji","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e18991_bib120","first-page":"1129","article-title":"Microbiome-metabolomics analysis reveals the protection mechanism of \u03b1-ketoacid on adenine-induced chronic kidney disease in rats","author":"Mo","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib121","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/s41467-019-09735-4","article-title":"Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease","volume":"10","author":"Kikuchi","year":"2019","journal-title":"Nat. Commun."},{"issue":"Pt 11","key":"10.1016\/j.heliyon.2023.e18991_bib122","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1099\/mic.0.040618-0","article-title":"Long-term impacts of antibiotic exposure on the human intestinal microbiota","volume":"156","author":"Jernberg","year":"2010","journal-title":"Microbiology (Read.)"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib123","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1186\/s12967-022-03825-6","article-title":"Integrative metagenomic and metabolomic analyses reveal the role of gut microbiota in antibody-mediated renal allograft rejection","volume":"20","author":"Li","year":"2022","journal-title":"J. Transl. Med."},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2023.e18991_bib124","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jfma.2018.09.007","article-title":"Metabolome analysis for investigating host-gut microbiota interactions","volume":"118","author":"Chen","year":"2019","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.heliyon.2023.e18991_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2016.01144","article-title":"Gut microbiota profiling: metabolomics based approach to unravel compounds affecting human health","volume":"7","author":"Vernocchi","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.heliyon.2023.e18991_bib126","article-title":"MALDI-TOF based Metabolomic approach","volume":"1","author":"Kapoor","year":"2009","journal-title":"Int. J. Genet."},{"key":"10.1016\/j.heliyon.2023.e18991_bib127","article-title":"Metagenomics, metatranscriptomics, and metabolomics approaches for microbiome analysis:supplementary issue: bioinformatics methods and applications for big metagenomics data","volume":"12s1","author":"Aguiar-Pulido","year":"2016","journal-title":"Evol. Bioinf. Online"},{"key":"10.1016\/j.heliyon.2023.e18991_bib128","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3389\/fgene.2015.00348","article-title":"The road to metagenomics: from microbiology to DNA sequencing technologies and bioinformatics","volume":"6","author":"Escobar-Zepeda","year":"2015","journal-title":"Front. Genet."},{"key":"10.1016\/j.heliyon.2023.e18991_bib129","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1471-2105-14-112","article-title":"A systematic comparison of the MetaCyc and KEGG pathway databases","volume":"14","author":"Altman","year":"2013","journal-title":"BMC Bioinf."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e18991_bib130","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41588-018-0135-7","article-title":"The fecal metabolome as a functional readout of the gut microbiome","volume":"50","author":"Zierer","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.heliyon.2023.e18991_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.698337","article-title":"Nuclear magnetic resonance spectroscopy in clinical metabolomics and personalized medicine: current challenges and perspectives","volume":"8","author":"Letertre","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.heliyon.2023.e18991_bib132","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/bs.acc.2014.11.002","article-title":"Lipidomics: new insight into kidney disease","volume":"68","author":"Zhao","year":"2015","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.heliyon.2023.e18991_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113551","article-title":"An LC-MS\/MS analytical method for the determination of uremic toxins in patients with end-stage renal disease","volume":"191","author":"Ma","year":"2020","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib134","first-page":"5","article-title":"LC-MS\/MS in the clinical laboratory - where to from here?","volume":"32","author":"Grebe","year":"2011","journal-title":"Clin. Biochem. Rev."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e18991_bib135","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1159\/000494677","article-title":"Efficacy of probiotics supplementation on chronic kidney disease: a systematic review and meta-analysis","volume":"43","author":"Jia","year":"2018","journal-title":"Kidney Blood Press. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e18991_bib136","first-page":"203","article-title":"The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems","volume":"28","author":"Carabotti","year":"2015","journal-title":"Ann. Gastroenterol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e18991_bib137","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/ki.2015.255","article-title":"Probiotics and chronic kidney disease","volume":"88","author":"Koppe","year":"2015","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib138","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2020.1831339","article-title":"Molecular insights into probiotic mechanisms of action employed against intestinal pathogenic bacteria","volume":"12","author":"van Zyl","year":"2020","journal-title":"Gut Microb."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e18991_bib139","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/MOG.0b013e32834baa4d","article-title":"Probiotics and immune health","volume":"27","author":"Yan","year":"2011","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18991_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(01)00209-3","article-title":"Probiotics: potential pharmaceutical applications","volume":"15","author":"Kaur","year":"2002","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e18991_bib141","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1365-2672.2006.02963.x","article-title":"Probiotics and their fermented food products are beneficial for health","volume":"100","author":"Parvez","year":"2006","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.heliyon.2023.e18991_bib142","article-title":"Focus on the gut-kidney Axis in health and disease","volume":"7","author":"Stavropoulou","year":"2020","journal-title":"Front. Med."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e18991_bib143","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13080573","article-title":"The therapeutic strategies for uremic toxins control in chronic kidney disease","volume":"13","author":"Lu","year":"2021","journal-title":"Toxins"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e18991_bib144","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00018-021-04080-6","article-title":"Outlook on next-generation probiotics from the human gut","volume":"79","author":"De Filippis","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e18991_bib145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173802","article-title":"Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: a double-blind, randomised, placebo-controlled trial","volume":"12","author":"Villar-Garc\u00eda","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2023.e18991_bib146","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.2147\/IJN.S337427","article-title":"Advancements in the pharmaceutical applications of probiotics: dosage forms and formulation technology","volume":"16","author":"Baral","year":"2021","journal-title":"Int. J. Nanomed."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023061996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023061996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:42:40Z","timestamp":1783114960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023061996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":147,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2405844023061996"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18991","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic kidney disease and gut microbiota","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e18991"}}